Entyvio Safe, Effective for Ulcerative Colitis and Crohn’s, Studies Show

Entyvio Safe, Effective for Ulcerative Colitis and Crohn’s, Studies Show
Entyvio (vedolizumab) is safe and effective to treat adults with moderate-to-severe active ulcerative colitis (UC) and Crohn's disease (CD). These results come from eight real-world analyses presented by Takeda Pharmaceutical Company at 2017 Digestive Disease Week conference in Chicago, Illinois, May 6-9. Two analyses conducted by the U.S. VICTORY (Vedolizumab for Health OuTComes in InflammatORY Bowel Diseases) consortium, a partnership of 10 leading IBD centers from across the U.S.. support the efficacy of Entyvio. The consortium now includes in its database information from about 900 UC and CD patients taking Entyvio in a real-world setting in the U.S. The effica
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *